EDGAR Filing Documents for 0001511164-19-000056

Form 8-K - Current report:

SEC Accession No. 0001511164-19-000056

Filing Date

2019-05-10

Accepted

2019-05-10 13:45:26

Documents

Period of Report

2013-01-28

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	form8_k.htm	8-K	17907
2	RESIGNATION OF KRISTIAN SCHIORRING AS DIRECTOR, PRESIDENT AND CEO	exhibit10_1.htm	EX-10.1	827
3	APPOINTMENT OF JASON BLACK AS DIRECTOR, PRESIDENT AND CEO	exhibit10_2.htm	EX-10.2	815
4	ORDER GRANTING PETITION TO SET ASIDE ADMINISTRATIVE DISSOLUTION	exhibit10_3.htm	EX-10.3	1563
5	IMAGE	exhibit1011.jpg	GRAPHIC	124225
6	IMAGE	exhibit1021.jpg	GRAPHIC	242168
7	IMAGE	exhibit1031.jpg	GRAPHIC	354760
8	IMAGE	exhibit1032.jpg	GRAPHIC	426433
9	IMAGE	exhibit1033.jpg	GRAPHIC	267979
	Complete submission text file	0001511164-19-000056.txt		1971387

Mailing Address 320 SANTANA DRIVE, #C CLOVERDALE CA 95425

Business Address 320 SANTANA DRIVE, #C CLOVERDALE CA 95425 770-866-6250

Bioflamex Corp (Filer) CIK: 0001368620 (see all company filings)